GR1004988B - Liposomal formulation comprising phospholipids, lipids and a ladbane-type diterpene - Google Patents

Liposomal formulation comprising phospholipids, lipids and a ladbane-type diterpene

Info

Publication number
GR1004988B
GR1004988B GR20040100331A GR2004100331A GR1004988B GR 1004988 B GR1004988 B GR 1004988B GR 20040100331 A GR20040100331 A GR 20040100331A GR 2004100331 A GR2004100331 A GR 2004100331A GR 1004988 B GR1004988 B GR 1004988B
Authority
GR
Greece
Prior art keywords
lipids
ladbane
phospholipids
type diterpene
liposomal formulation
Prior art date
Application number
GR20040100331A
Other languages
Greek (el)
Inventor
Κωνσταντινος Δεμετζος
Κωνσταντινος Δημας
Σοφια-Μαρια Χατζηαντωνιου
Αριστειδης Γεωργοπουλος
Original Assignee
Medexis Αεβε
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medexis Αεβε filed Critical Medexis Αεβε
Priority to GR20040100331A priority Critical patent/GR1004988B/en
Publication of GR1004988B publication Critical patent/GR1004988B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

novel liposomal composition comprising a phospholipid, one or more lipids and a labdane type diterpene, wherein at least one of the lipidss carry a charge is disclosed. Said composition is suitable for use in the preparation of a pharmaceutical composition for use in the treatment of cancer.
GR20040100331A 2004-08-05 2004-08-05 Liposomal formulation comprising phospholipids, lipids and a ladbane-type diterpene GR1004988B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20040100331A GR1004988B (en) 2004-08-05 2004-08-05 Liposomal formulation comprising phospholipids, lipids and a ladbane-type diterpene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20040100331A GR1004988B (en) 2004-08-05 2004-08-05 Liposomal formulation comprising phospholipids, lipids and a ladbane-type diterpene

Publications (1)

Publication Number Publication Date
GR1004988B true GR1004988B (en) 2005-09-16

Family

ID=34955570

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20040100331A GR1004988B (en) 2004-08-05 2004-08-05 Liposomal formulation comprising phospholipids, lipids and a ladbane-type diterpene

Country Status (1)

Country Link
GR (1) GR1004988B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002525A1 (en) * 1989-08-17 1991-03-07 Lvmh Recherche Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it
WO2001034116A2 (en) * 1999-11-08 2001-05-17 P.N. Gerolymatos S.A. Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002525A1 (en) * 1989-08-17 1991-03-07 Lvmh Recherche Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it
WO2001034116A2 (en) * 1999-11-08 2001-05-17 P.N. Gerolymatos S.A. Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias

Similar Documents

Publication Publication Date Title
BRPI0608297A2 (en) liposome compositions
TR200000576T1 (en) A method for applying liposomal encapsulated taxane
GB0007419D0 (en) Composition
IL179012A (en) Pharmaceutical composition comprising citerizine for the treatment of rhinitis, process for its preparation and uses thereof
WO2005065319A3 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
NZ541593A (en) Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
WO2006068759A3 (en) Liposomes containing phytochemical agents and methods for making and using same
WO2006050155A3 (en) Cancer therapeutic compositions
TW200600091A (en) Sulfonylethyl phosphorodiamidates
WO2009002867A3 (en) Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
WO2005065317A3 (en) Effervescent oral fentanyl dosage form
WO2006055352A3 (en) Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
WO2004045593A3 (en) Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
TW200642682A (en) A combination of medical drugs to augment the anti-cancer effect of chemotherapy
GT200500191A (en) DERIVADOS DE PIRIDO - PIRIMIDINA, ITS PREPARATION, ITS APPLICATION IN THERAPEUTICS
AR036321A1 (en) METHOD AND PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF LATE APPEARANCE DYSCINESIA.
MXPA05009137A (en) Liposome composition for reduction of liposome-induced complement activation.
GR1004988B (en) Liposomal formulation comprising phospholipids, lipids and a ladbane-type diterpene
TW200611697A (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
AR029451A1 (en) A COMPOSITION FOR USE IN THE BREAST CANCER THERAPY IN HUMAN BEINGS AND A PRODUCT FOR USE IN SUCH THERAPY
WO2007071205A3 (en) A taxane derivative containing pharmaceutical composition with improved therapeutic efficacy
WO2006125970A3 (en) Phospholipids for use in the treatment of an allergic inflammatory condition
SE0303135D0 (en) Controlled food effect composition
MXPA05009849A (en) Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor.
UA88468C2 (en) Sulfonylethyl phosphorodiamidates useful for treating cancer